News

A new study has found that a simple blood test may be a powerful way to detect early signs of Alzheimer’s disease, even in ...
Cognitive decline can range from mild forgetfulness to serious memory problems like dementia, which can affect a person’s ...
Bikers take on 3-day journey to raise awareness for Alzheimer’s. Over 400 bicyclists departed Simpsonville, SC Friday morning, and headed towards Charleston, SC, beginning the first ...
Gabapentin, which is used to treat seizures, nerve pain and restless leg syndrome might be linked with increased risk of ...
The new dosing schedule with a more gradual titration significantly lowered incidence of ARIA-E in the TRAILBLAZER-ALZ 6 trial.
The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...
A new dosing regimen for Kisunla, to help lower the risk of certain side effects, has been approved by the U.S. Food and Drug ...
A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...
With over 7 million Americans living with this disease, we need to do a better job of equipping primary care physicians with ...
China's top health authority has banned the use of a minimally invasive surgical procedure to treat Alzheimer's disease. The ...
A commonly prescribed pain medication—gabapentin—often considered a safer alternative to opioids for those who suffer from low back pain is now under scrutiny after being linked to increased risks of ...
Microglia replacement therapy helps treat people with a rare genetic condition called ALSP, suggesting the approach could ...